Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-06

Clinical Trial Update: Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment

View source ↗

Summary

A completed clinical trial evaluates the severity of overactive bladder symptoms in patients after Synergo treatment for bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Synergo

Snippet

Sponsor: Meir Medical Center | Conditions: Overactive Bladder, Bladder Cancer | Status: COMPLETED